Tenet Healthcare (THC) Current Deferred Revenue (2018 - 2023)

Tenet Healthcare has reported Current Deferred Revenue for 6 years, with the latest figure at $86.0 million in Q3 2023.

• Quarterly Current Deferred Revenue fell 22.52% year-over-year to $86.0 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $86.0 million (down 22.52% YoY) and the FY2022 annual result came in at $110.0 million, down 87.44% from the prior year.
• Current Deferred Revenue grew to $86.0 million in Q3 2023 per THC's latest filing, from $76.0 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $1.3 billion in Q3 2020 and troughed at $61.0 million in Q4 2019.
• A 5-year average of $465.7 million and a median of $257.0 million in 2022 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2020 and 2022: Current Deferred Revenue jumped 1789.55% in 2020, then tumbled 89.23% in 2022.
• Over 5 years, Current Deferred Revenue stood at $61.0 million in 2019, then surged by 736.07% to $510.0 million in 2020, then jumped by 71.76% to $876.0 million in 2021, then tumbled by 87.44% to $110.0 million in 2022, then declined by 21.82% to $86.0 million in 2023.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $86.0 million, $76.0 million, and $76.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.